关键词: COVID-19 Children Herbal medicine Pediatric Traditional medicine

Mesh : Betacoronavirus COVID-19 Child Coronavirus Infections / drug therapy Drugs, Chinese Herbal / therapeutic use Herbal Medicine Humans Medicine, Chinese Traditional Pandemics Phytotherapy Plants, Medicinal Pneumonia, Viral / drug therapy Practice Guidelines as Topic SARS-CoV-2 COVID-19 Drug Treatment

来  源:   DOI:10.1016/j.ctcp.2020.101174   PDF(Sci-hub)   PDF(Pubmed)

Abstract:
This review aimed to summarize and analyze the pattern identification (PI), herbal formulae, and composition of herbs provided by recent guidelines for the treatment of pediatric COVID-19. Seven data sources were reviewed until March 25, 2020. We analyzed the herbal formulae included in the guidelines and performed a network analysis to identify the frequency of herbs recommended in the herbal formulae. All 3 guidelines were provincial guidelines from China. Our results showed that there were 4 stages, 12 PIs, and 13 herbal formulae recommended by the provincial guidelines. These herbal formulae included a total of 56 herbs. Based on our network analysis, Scutellariae Radix was paired with Artemisiae Annuae Herba in one cluster. In another cluster, Armeniacae Semen was paired with Coicis Semen and Ephedrae Herba was paired with Gypsum Fibrosum. This review serves as a reference for the use of traditional medicine in the treatment of pediatric COVID-19.
摘要:
这篇综述旨在总结和分析模式识别(PI),草药配方,和最近的儿科COVID-19治疗指南提供的草药成分。在2020年3月25日之前,对七个数据来源进行了审查。我们分析了指南中包含的草药配方,并进行了网络分析,以确定草药配方中推荐草药的频率。所有3个指南都是来自中国的省级指南。我们的结果显示有4个阶段,12个PI,和省级指南推荐的13种草药配方。这些草药配方包括总共56种草药。根据我们的网络分析,黄芩与黄芩成簇。在另一个集群中,亚美尼亚精液与Coicis精液配对,以麻草与石膏纤维配对。该综述可为传统药物治疗小儿COVID-19提供参考。
公众号